238 related articles for article (PubMed ID: 31174402)
1. Exosomes Carry microRNAs into Neighboring Cells to Promote Diffusive Infection of Newcastle Disease Virus.
Zhou C; Tan L; Sun Y; Qiu X; Liao Y; Song C; Liu W; Nair V; Ding C
Viruses; 2019 Jun; 11(6):. PubMed ID: 31174402
[TBL] [Abstract][Full Text] [Related]
2. NDV related exosomes enhance NDV replication through exporting NLRX1 mRNA.
Xu X; Zhang D; Ding W; Wang W; Jin N; Ding Z
Vet Microbiol; 2021 Sep; 260():109167. PubMed ID: 34274763
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA gga-miR-455-5p suppresses Newcastle disease virus replication via targeting cellular suppressors of cytokine signaling 3.
Wang X; Jia Y; Ren J; Liu H; Xiao S; Wang X; Yang Z
Vet Microbiol; 2019 Dec; 239():108460. PubMed ID: 31767079
[TBL] [Abstract][Full Text] [Related]
4. Importance of retinoic acid-inducible gene I and of receptor for type I interferon for cellular resistance to infection by Newcastle disease virus.
Fournier P; Wilden H; Schirrmacher V
Int J Oncol; 2012 Jan; 40(1):287-98. PubMed ID: 21971670
[TBL] [Abstract][Full Text] [Related]
5. Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors.
Yaacov B; Eliahoo E; Lazar I; Ben-Shlomo M; Greenbaum I; Panet A; Zakay-Rones Z
Cancer Gene Ther; 2008 Dec; 15(12):795-807. PubMed ID: 18535620
[TBL] [Abstract][Full Text] [Related]
6. Detection of viral components in exosomes derived from NDV-infected DF-1 cells and their promoting ability in virus replication.
Xu X; Qian J; Ding J; Li J; Nan F; Wang W; Qin Q; Fei Y; Xue C; Wang J; Yin R; Ding Z
Microb Pathog; 2019 Mar; 128():414-422. PubMed ID: 30597256
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 3 inhibits Newcastle disease virus replication through activation of pro-inflammatory cytokines and the type-1 interferon pathway.
Cheng J; Sun Y; Zhang X; Zhang F; Zhang S; Yu S; Qiu X; Tan L; Song C; Gao S; Wu Y; Ding C
Arch Virol; 2014 Nov; 159(11):2937-48. PubMed ID: 24934575
[TBL] [Abstract][Full Text] [Related]
8. Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection.
Buijs PR; van Eijck CH; Hofland LJ; Fouchier RA; van den Hoogen BG
Cancer Gene Ther; 2014 Jan; 21(1):24-30. PubMed ID: 24384773
[TBL] [Abstract][Full Text] [Related]
9. Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion.
García-Romero N; Palacín-Aliana I; Esteban-Rubio S; Madurga R; Rius-Rocabert S; Carrión-Navarro J; Presa J; Cuadrado-Castano S; Sánchez-Gómez P; García-Sastre A; Nistal-Villan E; Ayuso-Sacido A
Cells; 2020 Jun; 9(6):. PubMed ID: 32516884
[TBL] [Abstract][Full Text] [Related]
10. Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy.
Cheng X; Wang W; Xu Q; Harper J; Carroll D; Galinski MS; Suzich J; Jin H
J Virol; 2016 Jun; 90(11):5343-5352. PubMed ID: 27009956
[TBL] [Abstract][Full Text] [Related]
11. gga-miR-1603 and gga-miR-1794 directly target viral L gene and function as a broad-spectrum antiviral factor against NDV replication.
Chen Y; Zhu S; Hu J; Hu Z; Liu X; Wang X; Gu M; Hu S; Liu X
Virulence; 2021 Dec; 12(1):45-56. PubMed ID: 33372825
[TBL] [Abstract][Full Text] [Related]
12. Type I interferon-sensitive recombinant newcastle disease virus for oncolytic virotherapy.
Elankumaran S; Chavan V; Qiao D; Shobana R; Moorkanat G; Biswas M; Samal SK
J Virol; 2010 Apr; 84(8):3835-44. PubMed ID: 20147405
[TBL] [Abstract][Full Text] [Related]
13. Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells.
Jiang K; Song C; Kong L; Hu L; Lin G; Ye T; Yao G; Wang Y; Chen H; Cheng W; Barr MP; Liu Q; Zhang G; Ding C; Meng S
BMC Cancer; 2018 Jul; 18(1):746. PubMed ID: 30021550
[TBL] [Abstract][Full Text] [Related]
14. Newcastle disease virus selectively infects dividing cells and promotes viral proliferation.
Chu Z; Gao X; Liu H; Ma J; Wang C; Lu K; Han Q; Wang Y; Wang C; Adam FEA; Wang X; Xiao S; Yang Z
Vet Res; 2019 Apr; 50(1):27. PubMed ID: 30999941
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL.
Kazimirsky G; Jiang W; Slavin S; Ziv-Av A; Brodie C
Stem Cell Res Ther; 2016 Oct; 7(1):149. PubMed ID: 27724977
[TBL] [Abstract][Full Text] [Related]
16. Differential microRNA Expression in Newcastle Disease Virus-Infected HeLa Cells and Its Role in Regulating Virus Replication.
Chen Y; Zhu S; Pei Y; Hu J; Hu Z; Liu X; Wang X; Gu M; Hu S; Liu X
Front Oncol; 2021; 11():616809. PubMed ID: 34150610
[TBL] [Abstract][Full Text] [Related]
17. Construction of recombinant Newcastle disease virus Italien strain for oncolytic virotherapy of tumors.
Wei D; Sun N; Nan G; Wang Y; Liu HQ; Peeters B; Chen ZN; Bian H
Hum Gene Ther; 2012 Jul; 23(7):700-10. PubMed ID: 22372930
[TBL] [Abstract][Full Text] [Related]
18. Analysis of three properties of Newcastle disease virus for fighting cancer: tumor-selective replication, antitumor cytotoxicity, and immunostimulation.
Fournier P; Bian H; Szeberényi J; Schirrmacher V
Methods Mol Biol; 2012; 797():177-204. PubMed ID: 21948477
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Replication of Virulent Newcastle Disease Virus in Chicken Macrophages Is due to Polarized Activation of Cells by Inhibition of TLR7.
Zhang P; Ding Z; Liu X; Chen Y; Li J; Tao Z; Fei Y; Xue C; Qian J; Wang X; Li Q; Stoeger T; Chen J; Bi Y; Yin R
Front Immunol; 2018; 9():366. PubMed ID: 29670609
[TBL] [Abstract][Full Text] [Related]
20. Host CARD11 Inhibits Newcastle Disease Virus Replication by Suppressing Viral Polymerase Activity in Neurons.
Wang W; Chang X; Yao W; Wei N; Huo N; Wang Y; Wei Q; Liu H; Wang X; Zhang S; Yang Z; Xiao S
J Virol; 2019 Dec; 93(24):. PubMed ID: 31554683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
